Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-07-28

Clinical Trial Update: Determination of the Lowest, Safe and Effective Dose of Proellex [Phase 1, Phase 2]

View source ↗

Summary

This update reports Phase 1/2 efforts to identify the lowest dose of Proellex that is safe and effective for Amenorrhea.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Proellex (telapristone acetate)

Snippet

Sponsor: Repros Therapeutics Inc. | Conditions: Amenorrhea | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2014-07-28